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Erasure of epigenetic memory is required to convert somatic cells towards pluripotency.
Reactivation of the inactive X chromosome (Xi) has been used to model epigenetic
reprogramming in mouse, but human studies are hampered by Xi epigenetic instability and
difﬁculties in tracking partially reprogrammed iPSCs. Here we use cell fusion to examine the
earliest events in the reprogramming-induced Xi reactivation of human female ﬁbroblasts. We
show that a rapid and widespread loss of Xi-associated H3K27me3 and XIST occurs in fused
cells and precedes the bi-allelic expression of selected Xi-genes by many heterokaryons
(30–50%). After cell division, RNA-FISH and RNA-seq analyses conﬁrm that Xi reactivation
remains partial and that induction of human pluripotency-speciﬁc XACT transcripts is rare
(1%). These data effectively separate pre- and post-mitotic events in reprogramming-induced
Xi reactivation and reveal a complex hierarchy of epigenetic changes that are required to
reactivate the genes on the human Xi chromosome.
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X
chromosome inactivation (XCI) is an exemplar of
epigenetically regulated silencing used by mammals
to compensate for gene dosage between males (XY) and
females (XX)1. XCI is a multi-factorial and multi-step process
that is established as pluripotent cells of the embryo differentiate
and can be reversed when somatic cells re-acquire pluripotency2.
Non-coding Xist RNA initiates inactivation by coating
the presumptive inactive X chromosome (Xi)3 and creating
a nuclear domain from which RNA polymerase II and
activating chromatin marks are excluded4,5. Several repressive
histone and DNA modiﬁcations including histone H3 lysine
27 tri-methylation (H3K27me3) and 5-methyl-cytosine are
incorporated within the chromatin of the Xi and result in
the stabilization of gene silencing6–8. Prior studies that
have examined the contribution of different XCI factors to this
silencing have shown that removal of XIST/Xist9,10 or H3K27me3
(refs 11,12) in somatic cells is insufﬁcient to reverse XCI but can
lead to sporadic gene reactivation when coupled to experimental
perturbation of histone acetylation or DNA methylation13.
Collectively such experiments contribute to the classical view
that components such as XIST/Xist and polycomb-mediated
histone modiﬁcations are required for the initiation but not
the maintenance of Xi silencing. Recently, however, it was
shown that loss of Xist, when combined with multiple cell
divisions, could lead to the consistent reactivation of some
genes along the Xi chromosome14. This suggests that while
control of Xi silencing is multi-layered and partially redundant,
different domains on the Xi may vary in susceptibility to
epigenetic reactivation.
In somatic cells the induction of pluripotency can result in
reactivation of the silent Xi. A strong correlation between
pluripotency and X chromosome reactivation (XCR) has been
shown in mouse in experimental reprogramming studies, as
well as in vivo during normal pre-implantation and primordial
germ cell development15. Model systems where XCI and its
reversal can be induced have allowed the molecular interactions
between the pluripotency network and XCI to be dissected.
For example, several mouse pluripotency-associated transcription
factors including Oct4, Nanog and Rex1 have been shown to
control XCI by regulating the transcription of Xist or its
antagonist Tsix2,16–18. In addition, a better understanding of the
contribution of different factors in maintaining Xi gene silencing
has been achieved by identifying the intermediate steps and
the dynamics of XCR during somatic cell reprogramming19.
Comparable studies in human cells have been more problematic.
This arises from the fact that human embryonic stem cells
(hESCs) and reprogrammed human induced pluripotent stem
cells (hiPSCs) with two active X chromosomes are notoriously
unstable in culture20–24. Cultured human pluripotent cells are
prone to undergo unscheduled re-initiation of XCI25,26, followed
by epigenetic ‘erosion’ and inappropriate loss of silencing27.
Dynamic studies of XCR in human cells have, therefore, been
hampered by epigenetic instability in culture and the consequent
selective pressures that environmental conditions, such as
oxygen tension, impose (reviewed in ref. 28). To circumvent
these limitations, we have utilized cell–cell fusions of somatic
and ESCs to generate transient human–mouse heterokaryons in
which the earliest steps of pluripotency-induced reprogramming
could be followed.
Previously, studies of fusions between cells of different types
had provided some of the ﬁrst evidence that XCR was associated
with pluripotency29. In early studies, in which human somatic
and rodent pluripotent and embryonic carcinoma cells were fused
to generate stable hybrid cell clones, reactivation of human
Xi-linked genes was demonstrated and enhanced by treatment
with drugs that inhibited DNA methylation30–33. These studies
also noted that in several human–rodent hybrid lines the
distribution of XIST RNA was also perturbed3,34,35, raising
concerns that there might be an intrinsic incompatibility
between human and mouse/hamster/rat cells. Here we used cell
fusion to examine the earliest events in human XCR. Rather
than examining conventional human–rodent hybrids that
contain a limited human chromosome contribution36, we
analysed XCI in newly formed heterokaryons before and just
after the ﬁrst mitosis. This system has the advantages of being
able to monitor the immediate events in reprogramming with
higher efﬁciencies than the iPSC system and to track cells
undergoing reprogramming more easily.
To investigate the dynamics and extent of human XCR induced
by pluripotent reprogramming we fused human female ﬁbroblasts
(hF) with mouse embryonic stem cells (mESCs). Previous
studies have shown that following cell fusion an ensemble of
mESC-factors is available to the human nucleus and that this
stimulates a rapid reactivation of the human pluripotency
network, accompanied by global chromatin changes and the
functional resetting of lineage potential37,38. Here we show that
immediately after cell fusion, human and mouse genomes remain
separate until the ﬁrst mitosis when hybrid cells arise39, and that
human pluripotency genes are re-expressed ahead of cell division.
During this early period, we show that human nuclei undergo a
progressive loss of H3K27me3 and XIST from the Xi and
selectively re-express certain human Xi genes. These data suggest
that XIST loss although necessary may be insufﬁcient for Xi
reactivation, and reveal that that reprogramming of human
female somatic cells can induce the reactivation of speciﬁc Xi
genes ahead of mitosis.
Results
Pluripotent reprogramming of human female ﬁbroblasts.
In order to investigate human XCR during pluripotent
reprogramming we ﬁrst examined the epigenetic signatures of the
two X chromosomes in female diploid ﬁbroblasts by ﬂuorescence
in situ hybridization (FISH), 4,6-diamidino-2-phenylindole
(DAPI) staining and the distribution of modiﬁed histones
(Fig. 1a). In the nuclei of female hF, the Xi is condensed during
interphase and forms a heterochromatin compartment identiﬁed
as the DAPI-dense Barr body. This compartment is coated by
XIST RNA and enriched in H3K27me3, as well as other histone
modiﬁcations associated with silencing6. Before reprogramming,
karyotype analysis and DNA-FISH revealed that most ﬁbroblasts
had two X chromosomes (490%) and labelling with
anti-H3K27me3 antibodies clearly identiﬁed a single Barr body
in 86% of cells (Fig. 1a). Further conﬁrmation was provided by
simultaneous RNA-FISH labelling with probes recognizing
XIST and ATRX (an X-linked gene), where XIST RNA painted
the Xi and nascent ATRX transcripts marked the location of
the active X chromosome (Xa) (Fig. 1a, middle panels).
Fibroblasts were then immortalized by human TERT
transduction to alleviate senescence24 and the Xi status was
revalidated before reprogramming.
Female hF and male mESCs were fused in equal ratio and
the kinetics of reprogramming and XCR was followed in
heterokaryon and hybrid cells generated over the next 6 days.
To identify and enrich for fused (hFxmESC) cells we used two
different approaches. In the ﬁrst approach, Hprt-null mESCs that
carry a puromycin resistance gene (PuroR) were fused with
primary or TERT-immortalized human ﬁbroblasts and
inter-species heterokaryons were selected by HAT/puromycin
(Fig. 1b). Alternatively, we directly isolated fused cells based
on the simultaneous expression of histone H2B-mCherry
(mESC) and HP1a-green ﬂuorescent protein (hF), as shown
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in Supplementary Fig. 1a. In both reprogramming models, we
conﬁrmed an up-regulation of human pluripotency genes (OCT4,
NANOG, CRIPTO, REX1) and a down-regulation of human
ﬁbroblast-associated genes (DCN, COL6A3) (Fig. 1c and
Supplementary Fig. 1b), as previously reported37,40,41. Analysis
of fused hFxmESC (H2B-mCherryþ /HP1a-green ﬂuorescent
protein (GFP)þ cells, enriched by ﬂuorescence-activated cell
sorting) showed that human pluripotency gene expression
was evident 2 days after fusion at a time when there is no cell
division (Supplementary Fig. 1c). Live-cell imaging of
these cultures conﬁrmed that fusion between individual nuclei
within heterokaryons (green–red) generates hybrids from day 3
onwards as some fused cells begin to enter their ﬁrst mitosis
(Supplementary Fig. 1d,c, hybrid cells increase from o5% at day
2 to 45% at day 4). This approach, therefore, allowed us to
examine the earliest events in reprogramming-mediated Xi
reactivation that occurred ahead of or immediately following
the ﬁrst cell cycle.
Reprogramming triggers global changes in human Xi chromatin.
As XIST RNA is a key regulator of XCI we analysed its
distribution in human nuclei before and after fusion with mESCs
(Fig. 2a). Before fusion, most human ﬁbroblasts showed a
compact XIST signal (Fig. 2a) that overlapped the X chromosome
territory (Supplementary Fig. 2a). After fusion, an increasing
proportion of cells showed a diffuse XIST RNA signal that was no
longer conﬁned to the territory of the human X chromosome
(Supplementary Fig. 2b). By day 3, 50% of heterokaryons had
diffuse XIST signals (Fig. 2a,b and Supplementary Fig. 2b) and a
minority of cells (E10%) had no detectable XIST. The proportion
of fused cells showing diffuse XIST signals remained reasonably
constant over the next few days (day 4–6) as the number of
hybrid cells increased. As Xist expression has been shown to
diminish during mouse iPSC reprogramming42, we assessed the
level of the spliced human XIST transcripts by quantitative
reverse transcription (qRT)–PCR. XIST transcript levels did not
appreciably change over 4 days following cell fusion (Fig. 2c),
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Figure 1 | Human female XaXi ﬁbroblasts are reprogrammed via cell-fusion with mouse embryonic stem cells. (a) Confocal images of normal XaXi
female hF (IMR90) where the Xi is visible as a DAPI-dense region, enriched for H3K27me3 histones (arrowhead, top panels) and coated by XIST
RNA (arrowhead, middle panels). The Xa is instead revealed by ATRX nascent transcript detection (open arrow, middle panels). Two X
chromosomes were conﬁrmed by labelling the ATRX locus and the whole X chromosome using DNA-FISH (bottom panels; Z95% in primary or
TERT-overexpressing cells). Total number of cells (n) was 4200 per experiment in at least two independent cultures. Scale bar, 5 mm.
(b) Scheme representing the strategy for reprogramming human ﬁbroblasts towards pluripotency. hF are fused with a male mESC line (E14Tg2a)
that is sensitive to HAT (Hprt /y) and resistant to puromycin (PuroR). Heterokaryons containing discrete nuclei from both partners were selected
by HAT/puromycin and generate drug-resistant hybrids after the ﬁrst cell division. (c) Histogram plots showing the expression of human
pluripotency genes (OCT4, NANOG, CRIPTO and REX1) and ﬁbroblast-speciﬁc genes (DCN, COL6A3) in the HAT/puromycin resistant cultures
where unfused hF, mESCs, H1 hESCs and primary mouse embryonic ﬁbroblasts (MEF) provide controls. Gene expression is reported as 2DCt
relative to GAPDH and represents the average of 3–10 independent experiments. Error bars indicate s.e.m. and (*) mark values that signiﬁcantly
differ from hF/day 0 (Pr0.05, two-sided t-test). See also Supplementary Fig. 1.
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Figure 2 | XIST RNA delocalization and loss of H3K27me3 enrichment at the Xi are early events in cell fusion-mediated reprogramming. (a) Confocal
images showing XIST RNA distribution in hF nuclei before and after fusion with mESCs. Three distinct XIST patterns were discriminated based on the pixel
proﬁle of the signal: a ‘compact’ XISTsignal spanning at least 2 mm with constant pixel intensity; a ‘diffuse’ signal with discontinuous peaks (o 2 mm); and a
signal with same intensity as background, classiﬁed as ‘no XIST’. Proﬁles show the pixel intensity for DAPI staining (blue) and XIST signal (red) along the
white line traced through the nucleus. Image scale¼ 6,247 pixels mm 1. (b) Percentage of human nuclei showing the three different XIST patterns
represented in (a) at successive days after mESC-fusion. At day 3, fused cells were exclusively heterokaryons (homokaryons and unfused cells not scored).
From day 4–6, hybrid cells were detected at increasing frequency (60–92%). Data-points represent the average of independent biological
replicates±s.e.m. and curves show B-spline ﬁtting. (*) indicates signiﬁcant changes versus day 0 (Pr0.05; two-sided t-test). Total number of scored cells
and number of replicate experiments are in parenthesis along the x axis. (c) Abundance of XIST spliced RNA measured by RT–qPCR with two different
human-speciﬁc primer sets that span distinct exon–exon junctions. Data are reported as 2DCt relative to GAPDH and represent the mean of three
independent experiments±s.e.m. No signiﬁcant difference was detected (P40.05; two-sided t-test) (d) Confocal images of hFxmESC heterokaryons at
day 3 with (arrowhead) and without a H3K27me3-enriched nuclear domain. Scale bar, 5 mm. (e) Percentage of hFxmESC heterokaryons (dark green circles)
or unfused hF on the same slide (light green circles) with a H3K27me3-enriched nuclear domain at 0, 1, 2 and 3 days after fusion. Data are represented as
in (b) and percentage of heterokaryons with a compact XIST signal (black squares) are shown within the plot to facilitate comparison. See also
Supplementary Fig. 2.
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suggesting that XIST RNA is delocalized, but is not silenced
during reprogramming. To verify that XIST delocalization
was a speciﬁc response to pluripotent conversion rather than a
response to heterokaryon formation per se, we fused female hF
with mouse B (mB) cells and assessed human XIST distribution
upon culture in mouse ESC medium. In these fused cells, human
XIST RNA remained tightly localized with the DAPI-dense
presumptive Xi in the majority of heterokaryons analysed
at day 3 (Supplementary Fig. 2c, quantiﬁed in Supplementary
Fig. 2d). At later time points (day 6) we observed a decline in
hFxmB cells showing compact XIST signals (Supplementary
Fig. 2d, grey) consistent with cells entering mitosis and loosing
chromosome-bound XIST RNA43 (Supplementary Fig. 2e).
To examine whether Xi-associated H3K27me3 was also
redistributed in human nuclei undergoing reprogramming we
performed immunoﬂuorescence analyses. H3K27me3 labelled
the Barr body in 480% of female hF, but this association
was progressively lost in heterokaryons formed with mESCs
(Fig. 2d,e). Three days after fusion most human nuclei (60%)
lacked both XIST and H3K27me3 at the presumptive Xi. These
results indicate that extensive remodelling of the human Xi
occurs early in pluripotent reprogramming, ahead of hybrid cell
formation and the ﬁrst cell division.
ATRX andHUWE1 are reactivated early during reprogramming.
Previous studies have indicated that loss of Xist/XIST does not
lead to re-expression of X-linked genes in somatic cells9,10. To
determine the transcriptional state of the human X chromosomes
during reprogramming, we carried out RNA-FISH for two
X-linked genes (ATRX and HUWE1) before and after the
fusion of hF with mESC (Fig. 3). The majority of ﬁbroblasts
had a single RNA signal for ATRX and HUWE1, consistent with
mono-allelic expression of both genes. We observed a progressive
increase in the percentage of human nuclei with two discrete
RNA signals in heterokaryons and hybrid cells following fusion
(Fig. 3a,b), where co-labelling with mouse Cot-1 probe was used
to discriminate human and mouse nuclei (as described in the
online Methods). Sequential RNA/DNA-FISH conﬁrmed that the
detection of two RNA signals per nucleus (at more than 1mm
distance) represents bi-allelic expression of X-linked genes
(420% at day 3), rather than locus replication (Supplementary
Fig. 3a). We observed a similar proportion of heterokaryons
showing two HUWE1 or ATRX signals (approximately a third,
Fig. 3b) and simultaneous RNA-FISH labelling of both
loci (Supplementary Fig. 3b,c) conﬁrmed that most cells
showing bi-allelic expression of ATRX also expressed HUWE1
bi-allelically, and vice-versa (Supplementary Fig. 3b,c). As
expected, control hFxmB fused cells showed no evidence of
bi-allelic expression of either of the genes (Supplementary
Fig. 3c). These data showed that cell fusion-mediated
pluripotent reprogramming of human ﬁbroblasts could induce a
switch from mono-allelic to bi-allelic expression of ATRX and
HUWE1. To investigate whether XIST delocalization was likely to
be a prerequisite for reprogramming-induced XCR we performed
simultaneous RNA-FISH analysis for both XIST and ATRX
(or HUWE1) in hFxmESC heterokaryons. This revealed that
bi-allelic expression of ATRX or HUWE1 was not signiﬁcantly
detected in cells retaining a ‘compact’ XIST distribution, but was
seen among cells in which XIST signals were diffuse or lost
(Supplementary Fig. 3d) and that loss of Xi-associated XIST
preceded the bi-allelic expression of selected Xi-genes in
heterokaryons (Fig. 3d, 70% XIST diffuse or absent and 30%
bi-allelic ATRX/HUWE1). These data are consistent with the
delocalization of XIST from the Xi being required but insufﬁcient
for Xi gene reactivation.
The human long non-coding XACT RNA coats the Xa in
human pluripotent cells44 (illustrated in Supplementary Fig. 3e)
and has been implicated in erosion-mediated XCR in hESCs27.
We, therefore, examined XACT expression during cell
fusion-based reprogramming using RNA-FISH. XACT RNA
was detected in a minor proportion (o1%, Supplementary
Table 1) of hFxmESC fused cells from day 3 onwards and coated
either one or both human X chromosomes. Importantly, XACT
signals were exclusively seen in human hybrid cells (that is, were
not detected before mitosis) and were not predictive of bi-allelic
ATRX expression (illustrated in Fig. 3e,f). These data suggest that
XACT induction and Xi reactivation are temporally uncoupled in
this reprogramming scenario.
Partial reactivation of the human Xi upon reprogramming. To
examine reactivation of Xi-speciﬁc alleles at the molecular level,
we used single-nucleotide polymorphisms (SNPs) to distinguish
transcripts originating from each of the two X chromosomes. To
do this a human ﬁbroblast cell line carrying heterozygous SNPs in
ATRX and PHDA1 genes was used to derive clonal populations
where cells expressed the same X chromosome (X1 or X2; illu-
strated in the schematic representation shown in Fig. 4a).
Both alleles of ATRX and PDHA1 were expressed in the
original human ﬁbroblast line (hF complementary DNA),
whereas only one of the two alleles was detected (X1a or X2a) in
single-cell-derived clones (clone a1 and clone b1; Supplementary
Fig. 4a,b), consistent with mosaic expression of X-linked genes
and clonal epigenetic inheritance. To assess the reactivation
of Xi-alleles (X2i or X1i), we reprogrammed these clones by fusing
them with male mESCs (Supplementary Fig. 4c) and routinely
detected the re-expression of the previously silent ATRX allele
using two parallel approaches (Fig. 4b,c; described in the legends
and methods), as well as by RNA-FISH analysis (Supplementary
Fig. 4d). Although these data were consistent with previous
analysis showing that bi-allelic expression of ATRX was induced
upon reprogramming, another X-linked locus PDHA1 appeared
to be refractory to re-expression (Fig. 4b,c). This contrast in
behaviour suggested that reprogramming-mediated reactivation
might not be uniform along the Xi. Reactivation of ATRX but
not PDHA1 was consistently seen in fusions between different hF
clones and mESCs (Fig. 4b,c) but not in control fusions with
mouse somatic cells (Supplementary Fig. 4e). Importantly XIST
transcript levels remained constant (Supplementary Fig. 4f),
suggesting that XIST expression was not silenced in human cell
fusion-mediated reprogramming.
To evaluate the extent of XCR we performed RNA-sequencing
(RNA-seq) to determine allele-speciﬁc expression from the Xa
and Xi of hF (clone b1) before and 5–6 days after mESC-fusion
(Fig. 5a). Speciﬁcally, we analysed 113 human X-linked
genes in which 420 SNP-overlapping reads were detected
(Supplementary Data 1a). Among these, several genes showed
evidence of XCI-escape (nine candidates shown in blue, Fig. 5a)
being signiﬁcantly expressed from the Xi by the parental clone
ahead of fusion (day 0). Expression of several other Xi genes
was selectively seen in samples after fusion (GYG2, PRKX,
RP11-706O15.1, ARSD, PNPLA4, MID1, FUNDC1, WWC3,
TMSB4X, PIN4 shown in green), indicating reactivation-sensitive
candidates, whereas other genes remained refractory to
reactivation. To verify the status of candidates identiﬁed as being
sensitive or refractory to Xi-reactivation by RNA-seq, we
performed RNA-FISH to examine re-expression at the single cell
level (Fig. 5b). In the case of controls, such as HDAC8, robust
mono-allelic expression was observed before and after
reprogramming, conﬁrming that the Xi-allele of this gene was
not reactivated. In contrast, bi-allelic expression of candidates
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Figure 3 | Bi-allelic expression of human X-linked genes is associated with XIST de-localization but not with XACT re-expression. (a) Confocal images
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middle panels) and hybrids (bottom panels). Scale bar, 5mm. (b) Histogram plots represent the percentage of hFxmESC heterokaryons containing 1, 2 or42
RNA signals. ATRX and HUWE1 percentages at day 3/4 are signiﬁcantly different from day 0 (Pr0.05; two-sided t-test). Total number of cells and number of
replicate experiments are shown in parenthesis. Plots represent only heterokaryons; similar percentages of hybrids with two RNA signals were detected at day
4 (22% for ATRX; n¼ 148). (c) Confocal images showing simultaneous detection of XIST RNA and nascent X-linked gene transcripts (that is, ATRX or HUWE1)
in hFxmESC heterokaryons with distinct XIST distribution patterns. Proﬁles show the pixel intensity for DAPI (blue), ATRX/HUWE1 transcripts (red) and XIST
RNA (green) across the human nucleus; image scale¼ 10,422 pixelsmm 1. Scale bar, 5mm. (d) Quantiﬁcation of the patterns in (c). Cells that no longer have
a compact XIST signal (that is, XISTdiffuseþ no signal) were scored together. Graphs represent the average of at least two independent experiments±s.e.m.
and B-spline ﬁtting (lines). (*) indicate signiﬁcant changes (Pr0.05, two-sided t-test). Total number of cells scored at 0, 1, 2 and 3 days after fusion are 201,
168, 119 and 94 for HUWE1 and 48, 99, 55 and 44 for ATRX, respectively. All scored cells were heterokaryons. (e) Confocal image showing three
representative post-mitotic hybrids in which XACT RNA and nascent ATRX transcripts are simultaneously detected. XACT coats either one or two X
chromosomes but none of the observed XACT patterns correlates with bi-allelic ATRX expression. Xa* indicates a putative reactivated X chromosome that
transcribes ATRX but lacks XACT. Scale bar, 5mm. (f) Quantiﬁcation of XACT positive and ATRX bi-allelic cells in (hFxmESC) heterokaryons and hybrids at
successive days after fusion. Hybrids represented 30, 56 and 49% of total at day 3, 4 and 6, respectively. See also Supplementary Fig. 3.
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Figure 4 | Allele-speciﬁc expression analysis of ATRX and PDHA1 during cell fusion-mediated reprogramming reveals partial Xi reactivation.
(a) Schematic representation of the experiments. Mosaic female hF (NHDF17914) that carry heterozygous SNPs within ATRX and PDHA1 alleles on different
X chromosomes (X1 and X2) were cloned by limiting dilution to obtain clones (type a or b) homogeneously expressing either one or the other allele (Xa1Xi2
or Xi1Xa2). SNP-speciﬁc expression analysis was then used to investigate reactivation of Xi-alleles upon hFxmESC fusion. (b,c) Two different experimental
approaches showed reactivation of ATRX - but not PDHA1 - upon mESC-fusion of different hF clones. In the ﬁrst approach (b), ATRX and PDHA1 alleles
were analysed by enzymatic digestion of PCR products ampliﬁed from single-strand complementary DNA (sscDNA). Alleles on the two different X
chromosomes generated restriction fragments of distinct lengths and were discriminated by agarose gel separation (restriction length polymorphisms
analysis)53. Red arrow in the top panels highlights the ATRX allele that was reactivated upon hFxmESC fusions. In the second approach (c), restriction
digestion was directly performed on double-strand cDNA (dscDNA) without prior ampliﬁcation and a quantitative PCR strategy was used for determining
expression of digestion-sensitive SNP and control sites along ATRX and PDHA1 genes (top schematic and Methods). Histogram plots represent the
percentage of allele 1 expression before and after fusion of human ﬁbroblast clones. Data are shown as mean±s.e.m. of two independent experiments with
a1/a2 (white bars) and b1/b2 (grey bars) clones. Genomic DNA from hF clones and plasmids with sub-cloned SNP sites for allele 1 or allele 2 were used as
controls (black bars). (*) indicate values that signiﬁcantly differ from hF/day 0 (Pr0.05, two-sided t-test). See also Supplementary Fig. 4.
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such as WWC3 and RP11-706O15.1 was evident only after
mESC-fusion (Fig. 5b), conﬁrming sensitivity to XCR.
Importantly, bi-allelic expression of such genes was evident
within heterokaryons (as illustrated for WWC3 in Fig. 5b)
consistent with Xi reactivation occurring before the ﬁrst cell
division.
To further examine the extent of Xi-reactivation induced by
reprogramming we performed RNA-FISH by using a mixture of
commercially available probes that span the human X chromo-
some (X paint) but lack repetitive CotI elements27 (see methods).
This allowed ’domains’ of gene expression to be evaluated at the
single cell level in hF before and after mESC-fusion (Fig. 5c and
Supplementary Fig. 5a). A single transcriptional domain (Xa) was
detected in individual ﬁbroblast nuclei ahead of fusion, while two
domains (Xa and Xa*) were evident in 24–38% of heterokaryons
and hybrids examined at days 4–6 (Fig. 5c, Supplementary
Fig. 5a,b). In these nuclei, we noted that one transcriptional
domain (Xa*) was reproducibly smaller than the other (Xa), an
observation that was conﬁrmed by detailed volumetric assessment
(Fig. 5d). To understand the basis for this difference, we
examined hFxmESC in which either one (single domain) or
two X transcriptional domains were detected (by RNA-FISH), using
sequential X-DNA FISH to estimate the underlying chromosome
volumes (Supplementary Fig. 5c). This analysis showed that
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Figure 5 | The human Xi is partially reactivated upon cell fusion-mediated reprogramming. (a) Expression of human Xi transcripts examined by allele-
speciﬁc RNA-seq in female human ﬁbroblasts (clone b1) before (day 0) and after (day 5/6) mESC-fusion. Data points show Xi expression of 113 genes along
the X chromosome (x axis) where genes that escape XCI before reprogramming (blue closed circles),, or that are sensitive to reactivation following fusion
(day 5 green open circles; day 6 green closed circles) are highlighted. Xi expression is represented as the ratio of reads overlapping the minor (Xi) allele versus
the total of both alleles (XiþXa) and result from two biological replicates. Genes were classiﬁed accordingly to Xi expression ratio and signiﬁcance62, as
detailed in the Methods. (b) RNA-FISH analyses of candidate reactivation-refractory (HDAC8) and reactivation-sensitive (RP11-706O15.1, WWC3) genes
in human ﬁbroblasts before (day 0) and after mESC-fusion (day 5). Histogram plots show the percentage of human nuclei (heterokaryon/hybrid cells;
n¼ 44/83, 33/74, 48/81 for HDAC8, RP11-706O15.1 and WWC3, respectively) with one, two, or42 punctate RNA signals. Representative confocal images
showing mono-allelic expression ofWWC3 (red) in human nuclei before (day 0) and bi-allelic expression after (day 5) mESC-fusion (arrowed) where mouse
nuclei were discriminated using mCotI probe (green). Arrows indicate transcribed loci (that is, punctate RNA signals). Scale bar, 5mm. (c) Confocal images of
hFxmESC heterokaryons where either one (top) or two (lower) transcribed X chromosomes (arrowed) were evident. Mouse Cot1 probe identiﬁes mouse
(ESC-derived) nuclei. X chr RNA paints were pre-treated with human Cot1 DNA to diminish the detection of repeat-rich elements63 within the transcribed
X chromosome domains. Xa* marks the smaller (and Xa the larger) domain. Scale bar, 5mm. (d) Box plots showing the volume of the RNA (top) and DNA
(bottom) X domains detected by sequential RNA/DNA FISH in hFxmESC expressing one (single domain) or two (two domains) X chromosomes (shown in
Supplementary Fig. 5b). Signiﬁcant volume differences are highlighted (P values) and were estimated byWilcoxon signed-rank test or Mann–Whitney test, for
the comparison of Xa/Xa* and Xa/Xi, respectively. Data represent at least 50 cells in each graph. See also Supplementary Fig. 5.
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although the reactivated Xa* chromosome occupied less volume
than Xa in hFxmESC cells expressing two X domains, the
Xi and the Xa* chromosome volumes were remarkably
similar (DNA volumes in Fig. 5d), indicating minimal
chromosomal de-condensation. These data suggest that
pluripotent reprogramming had induced a partial reactivation
of the Xi, consistent with RNA-seq analysis.
Discussion
In this study, we have generated transient heterokaryons to
examine the earliest events in human Xi-reactivation induced
by pluripotent reprogramming. We have shown that upon
fusion with mouse ESCs, female human ﬁbroblasts re-express
pluripotency genes and undergo a series of epigenetic changes
that culminate in the re-expression of selected X-linked genes.
Speciﬁcally reprogramming induced the loss of Barr body-
associated histone H3K27me3 and delocalization of XIST from
the human Xi, despite detection of XIST transcripts. These
changes in pre-mitotic human chromatin appeared to be
required for the subsequent re-expression of ATRX and HUWE1,
but were insufﬁcient to ensure the reactivation of many other
X-linked genes including PHDA1. Previous reports based on
studies of stable human–rodent hybrid clones had shown that
XIST could delocalize from the Xi in the absence of pluripotent
conversion3,34. However, we show here that XIST remained
focused at the human Xi in control heterokaryons generated with
somatic mouse B cells up until these cells enter mitosis.
This observation, together with recent reports showing that
XIST function relies heavily on a spectrum of different
human RNA-binding proteins45–47, suggests that the
reported delocalization of XIST in somatic cell hybrids probably
reﬂects the paucity of human chromosomes retained by these
cells rather than intrinsic species incompatibilities. In pre-mitotic
heterokaryons, we found that XIST delocalization strongly
correlated to pluripotency and preceded the bi-allelic expression
of ATRX and HUWE1 genes. Expression of human-speciﬁc
XACT RNA was, in contrast, a much later temporal event that
was only detected in a minority of hybrid cells after mitosis.
This suggests that XIST and XACT have distinct roles in initiating
and in maintaining Xi silencing and Xa activation, respectively.
Although the role of XACT in XCR will require further study, the
temporal separation of XIST removal and XACT detection
shown here makes it unlikely that these two RNA species act as
direct competitors in this reprogramming scenario. In human
pluripotent cells, it has been suggested that XIST is antagonized
by XACT binding along the X chromosome27. This hypothesis
was based on the observation that XACT coats the Xa in ‘primed’
hESCs (where XIST coats the Xi), and it localizes to the Xi ahead
of XIST loss during the erosion of gene inactivation27. Here we
show that XIST delocalization and partial Xi gene reactivation can
occur in the absence of XACT. This could be because XACT
expression requires the transition to a fully reprogrammed state,
or it has a role in stabilizing XCR, or simply because it is not
efﬁciently induced in an inter-species context.
The delocalization of XIST and loss of Barr Body-associated
H3K27me3 reported here is consistent with previous in vivo
studies showing that re-expression of Oct4 in developing
primordial germ cells is accompanied by loss of Xist and
H3K27me3 (refs 48,49). However, in contrast to what has been
reported for hiPSCs 26, XIST expression was not silenced during
cell fusion-mediated pluripotent reprogramming; rather, XIST
displayed a change in nuclear localization. This redistribution
could represent reduced binding of XIST to the Xi, or
alternatively be the result of global de-condensation of the Xi in
response to reprogramming and the inﬂux of factors such as
mouse-derived Oct4 (ref. 50). As we did not see evidence of any
signiﬁcant increase in the volume of the Xi during the ﬁrst few
days after cell fusion, our data support the former view that XIST
dissociates from the Xi early during pluripotent reprogramming.
This observation is consistent with studies in human blastocysts
where, before the onset of XCI, XIST is reported to be present but
is not tightly associated with the Xi51. Although our studies
showed that XIST delocalization was insufﬁcient to ensure global
XCR, cells that re-expressed ATRX and HUWE1 lacked XIST
or had a diffuse XIST distribution. This suggests that removal
of XIST from the Xi is necessary but not sufﬁcient for
reprogramming-induced XCR. In the mouse, gene silencing
relies on Xist for a brief period of time at the beginning of mouse
ESC differentiation52. It is conceivable that reprogramming of
somatic cells back to pluripotency might require a similar
‘window of opportunity’ or transient state in which the removal
of XIST from the Xi is required to reset gene activity.
Fusion of human somatic cells with mESCs triggers an inﬂux
of the mouse pluripotency factors into the somatic nucleus37.
The subsequent re-expression of human pluripotency genes
(OCT4, NANOG, CRIPTO and REX1) and later of XACT-RNA
demonstrates that a human-speciﬁc pluripotency network is
established following cell fusion and implies a certain degree of
conservation between human and mouse in the mechanisms
that lead to epigenetic reprogramming and XCR. Previous
studies in iPSCs have shown that reactivation of the human
Xi during pluripotent reprogramming is not achieved with
standard human ESC medium24,53, but instead requires
leukaemia inhibitory factor54 or GSK3/MEK inhibitors, together
with constitutive overexpression of pluripotency factors20,55.
Reprogramming using inter-species heterokaryons differs from
iPSC-based reprogramming in several important respects and
also offers some experimental advantages. For example, it allows
access to events that occur before mitosis and cell division
that are much less likely to depend on culture conditions. Using
this approach, we reafﬁrm that XCI is partially reversed by
pluripotent reprogramming of human somatic cells and describe
an ordered sequence of epigenetic changes that occur ahead of the
ﬁrst cell division (Supplementary Fig. 6). We observed rapid and
dynamic changes in histone H3K27me3 and XIST localization to
the Xi that preceded bi-allelic expression of a small subset of
X-linked genes. These data suggest that changes in chromatin
organization occur ahead of the de-repression of selected
X-linked genes. By examining heterokaryons and hybrid cells at
later time points we conﬁrmed that reactivation of the human Xi
remains partial, with only 10% of the examined candidate genes
switching to bi-allelic expression upon conversion towards
pluripotency. Although we do not currently know the basis for
the selectivity in genes showing reactivation this does not
correlate with obvious features such as DNA methylation or
proximity to CpG islands (personal communication, Bagci H.).
Future studies will be required to identify factors and chromatin
remodelling events that enable complete chromosome-wide Xi
reactivation in human reprogrammed cells, as such knowledge is
important to model X-linked diseases and for generating human
iPSCs for regenerative medicine56.
Methods
Cell culture and fusion. Human ﬁbroblast IMR90 (Coriell) and NHDF17914
(Lonza) were maintained in DMEM medium supplemented with 10% FCS, 1%
non-essential amino acids, 2mM L-glutamine and antibiotics (10 mgml 1
penicillin and streptomycin). Primary hF cell lines were immortalized with
pBABE-hTERT-blast and subsequently transduced with HP1aGFP-puroR
retroviral construct (IMR90-hTERT-HP1aGFP-puroR). Single-cell clones were
derived by limiting dilution in 3% O2 and clonal identity was conﬁrmed by
restriction-fragment length polymorphism analysis and Sanger sequencing of
heterozygous SNP loci (Supplementary Fig. 4a,b) showing the homogenous
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expression of only one of the two X-linked genomic alleles (that is, a single X
chromosome is expressed in each clone). Abelson-transformed mB and mESC
(established in our lab) were cultured as previously described37. E14Tg2a
Hprt /mESC (gift from Niall Dillon) were transfected with pCAG-puro57 or
pCAG-H2BmCherry-IRES-puro and stable clones were derived in 1.5 mgml 1
puromycin. Human ESCs (H1 and H9 lines; gift from Wei Cui and Molly Stevens,
respectively) were cultured in mTesR1 on Matrigel coated-dishes. For fusion
experiments, cells were mixed in 1:1 ratio and treated in suspension with
poly-ethylene-glycol (PEG 1500, Roche), as previously described37. Heterokaryons
and hybrids were cultured in mouse ESC medium supplemented with mouse
leukaemia inhibitory factor and selected after 12 h by adding puromycin
(1.5mgml 1) and HAT (20 mM hypoxantine, 0.08mM aminopterin, and 3.2mM
thymidine; Sigma), or puromycin (1.5 mgml 1) and blasticidin (2 mgml 1) for
hFxmESC and hFxmB, respectively. Cells obtained upon fusion of GFP-positive hF
with mCherry-positive mESCs were sorted twice at 24 and 48 h after fusion by
FACSAriaIII (BD). All the cell lines used in this study have been regularly tested for
mycoplasma contamination and resulted negative.
Immunoﬂuorescence and live-cell imaging. For immuno-staining, cells were
grown on gelatin-coated coverslips, ﬁxed with 2% paraformaldehyde for 15min at
room temperature and then permeabilized by 0.5% Triton-X-100 for 2min and
0.1% Triton-X-100 for 30min. Incubation in blocking buffer (2.5% bovine serum
albumin, 0.05% Tween-20, 10% goat serum in 1 PBS) was performed for
30minutes before labelling with primary H3K27me3 antibody (1:500, Upstate
05-581 or Diagenode CS-069-100) for 1 h 30min at room temperature. Cells were
then washed by 0.2% bovine serum albumin/0.05% Tween-20 in PBS and stained
with secondary antibodies (1:400, goat anti-mouse or goat anti-rabbit IgG
Alexa Fluor 488 conjugate, Molecular probes A-11029 and R37116) and
ﬂuorescently-labelled phalloidin (1:100, Alexa Fluor 568 or 647; Molecular probes
A12380 and A22287, respectively). Cells were ﬁnally mounted with Vectashield
medium containing DAPI (Vector labs) and imaged on a Leica SP5 II confocal
microscope. Human and mouse nuclei were distinguished based on DAPI-staining
and the presence of chromocenters in the mouse nuclei. Individual cells were
delineated by phalloidin and inter-species heterokaryons were identiﬁed as cells
containing two or more nuclei both of human and mouse origin, as illustrated in
Supplementary Fig. 1c.
Cells obtained after fusion between HP1a-GFP hF with H2B-mCherry mESCs
were attached on poly-L-lysine treated-coverslips immediately after sorting. In this
case, hybrids obtained upon fusion of the human and mouse nuclei could be
detected as cells with GFPþ /Cherryþ single nuclei (Supplementary Fig. 1c,d).
For time-lapse microscopy, sorted cells were plated on gelatinized dishes
(35mm m-Dish, IBIDI) and imaged every 3min for 18 h. Images were acquired at
Leica SP5 II confocal with  63/1.4NA HCX PL APO lambda blue objective and
processed by ImageJ58.
RNA and DNA-FISH. RNA and DNA-FISH were performed as previously
described7. Probes used in this study were obtained by nick translation
(Abbott Molecular) of plasmids, bacterial artiﬁcial chromosomes or mouse
Cot-1 DNA (Invitrogen) in the presence of ﬂuorophore-conjugated dUTPs
(ENZO). Bacterial artiﬁcial chromosomes used for the synthesis of ATRX, HUWE1,
HDAC8, RP11-706O15.1 and WWC3 probes were RP11-42M11, RP11-155O24,
RP11-1021B19, WI2-1543K8 (CHORI), and CTD-2277I2 (Invitrogen),
respectively. XIST probes were synthesized from G1A plasmid (gift from J.B.
Lawrence) containing 10 kb from the fourth intron to the 30-end of the gene, and
from a plasmid containing XIST exon1.
RNA-FISH for detecting transcribed domains on the human X chromosome
was performed by using human X chromosome paint (Cambio), as previously
detailed27. Brieﬂy, 5 ml of concentrated X paint was mixed with 5 mg of human Cot1
DNA (Life Technologies), denatured for 7min at 75 C and pre-annealed for
30min at 37 C in order to deplete the probe of Cot1 repeats before hybridizing
with cells overnight at 37 C.
In order to identify heterokaryons and hybrids, slides were automatically
acquired at low resolution with a  20/0.7NA CS HC PL APO objective by using
Leica SP5 confocal microscope and LAS AF Matrix Screener software. Images were
then analysed by ImageJ to ﬁnd the coordinates of heterokaryons that showed
partially overlapping signals for mouse-speciﬁc Cot-1 repeats and human-speciﬁc
X-linked gene probes. Selected positions were then acquired at higher resolution by
 63/1.4NA HCX PL APO lambda blue objective (z¼ 0.2 mm). Images were
processed and analysed by ImageJ. Volumetric analysis was performed by
NEMO/3D-FISH plugin59.
RNA extraction and RT–PCR. Total RNA extraction and SYBR-Green RT–qPCR
were performed as previously described in ref. 37. Primers used in this study are
reported in Supplementary Table 2. XIST allele-speciﬁc expression (Supplementary
Fig. 4f) was analysed by Taqman PCR performed with SNP genotyping assay
(rs1620574; assay ID C-7626536_10 Applied Biosystems) and Taqman Universal
Master Mix No AmpEraseUNG (Applied Biosystems) according to the manu-
facturer instructions.
SNP-restriction assays. Restriction-fragment length polymorphism analysis for
ATRX and PDHA1 was carried out as previously described53. Speciﬁcity of the
primers for human transcripts was validated by performing RT–PCR on mESCs.
For quantitative analysis of restriction digestion-sensitive SNPs (Fig. 4c),
double-stranded complementary DNA was generated from 1 mg total RNA via
SuperScript kit (Invitrogen), puriﬁed with Agencourt AMPure XP beads (Beckman
Coulter) and digested by BseRI or PstI for ATRX and PDHA1, respectively.
SYBRgreen PCR was performed upon digestion by using primers reported in
Supplementary Table 1. Allele1 expression was quantiﬁed using primers spanning
the restriction-sensitive SNP site (red arrows in Fig. 4c) and normalized versus the
total expression of allele1 and 2 (ampliﬁed by the black and red primers in the
dashed rectangle; Fig. 4c). Allelic ratios were further normalized for the digestion
efﬁciency, which was estimated by quantifying the expression of a control
restriction site within the same exon containing the SNP site (grey arrows).
RNA-seq and bioinformatic analysis. RNA-seq libraries were prepared from
0.6 mg of total RNA (RNA integrity number (RIN)47.5) by True-seq RNA sample
prep v2 kit (Illumina) and were ampliﬁed by 13 PCR cycles. Paired-end 100 bp
reads were generated using HiSeq2500 sequencer (Illumina). RNA-seq reads from
two biological replicates of hF clone b1 before (day 0) and after (day 5) fusion were
aligned independently to human (hg19, Ensembl gene version 72) and mouse
reference genomes (mm9, Ensembl gene version 67) using Tophat v2.0.8 (ref. 60).
The sequencing reads aligning to both human and mouse genomes were excluded
and only human-speciﬁc reads were considered for allelic expression analysis. In
order to estimate allelic expression, we used a set of 379 heterozygous SNPs
previously identiﬁed across 183 genes by performing RNA-seq of two isogenic
clones with opposite haplotype expression (for example, a1 and b1) and selecting
genomic positions with a different base in the two clones. The number of SNP-
overlapping reads for each allele was obtained using SAMtools mpileup61. At each
SNP position the allele representing the majority of reads in hF before fusion
(day 0) was considered as the major allele (Xa) and the other the minor allele (Xi).
Xa- and Xi- alleles identiﬁed at day 0 were then used to compare allelic expression
in samples after fusion. Allelic expression was calculated as the sum of reads
overlapping the Xa or Xi alleles (identiﬁed by SNPs) for each gene, and is
represented as ratio of Xi/(XaþXi). A gene was considered expressed from the Xi
when its Xi ratio was higher than 10% or when it had a signiﬁcant ‘probability of
escaping XCI’ (that is, being expressed from the Xi, t0 r0.05) based on a
previously described beta-binomial model62. Brieﬂy, this allows the probability that
a gene is expressed from the Xi to be estimated based on the total number of reads
obtained from the Xi allele, the sum of the base quality scores for the Xi-SNPs
within these reads, and the Xi/(XiþXa) ratio. RNA-sequencing data were ﬁtted to
a mixture of beta-binomial distribution in order to determine signiﬁcant Xi
expression and obtain the probability of escape (t0). To increase conﬁdence in
annotation, only genes with minimum 20 SNP-overlapping reads at day 0 and at
day 5 were considered (n¼ 113, Supplementary Data 1).
Genes were classiﬁed into three groups according to allelic expression in hF
clone b1: (i) genes that escaped XCI and showed signiﬁcant Xi expression before
(day 0) and after fusion (day 5) (Fig. 5a and Supplementary Data 1, blue), (ii) genes
that showed signiﬁcant Xi expression after fusion (day 5) but not before (day 0)
and represent reactivation-sensitive candidates (shown in green, Fig. 5a and
Supplementary Data 1) and (iii) genes that were refractory to Xi reactivation and
showed no signiﬁcant Xi expression at day 0 or after fusion (shown in black, Fig. 5a
and Supplementary Data 1). Additional analyses of samples obtained slightly later
after fusion were performed as outlined above and identiﬁed three additional
reactivation-sensitive genes that had signiﬁcant Xi expression at day 6 (but not at day 0):
WWC3, TMSB4X and PIN4 (Fig. 5a and Supplementary Data 1b).
Data availability. RNA-seq data set has been submitted to gene expression
omnibus (GEO), with accession number GSE77443.
References
1. Lyon, M. F. Gene action in the X-chromosome of the mouse (Mus musculus L.).
Nature 190, 372–373 (1961).
2. Navarro, P. & Avner, P. When X-inactivation meets pluripotency: an intimate
rendezvous. FEBS Lett. 583, 1721–1727 (2009).
3. Clemson, C. M., Chow, J. C., Brown, C. J. & Lawrence, J. B. Stabilization and
localization of Xist RNA are controlled by separate mechanisms and are not
sufﬁcient for X inactivation. J. Cell Biol. 142, 13–23 (1998).
4. Chaumeil, J., Le Baccon, P., Wutz, A. & Heard, E. A novel role for Xist RNA in
the formation of a repressive nuclear compartment into which genes are
recruited when silenced. Genes Dev. 20, 2223–2237 (2006).
5. Jeppesen, P. & Turner, B. M. The inactive X chromosome in female mammals
is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for
gene expression. Cell 74, 281–289 (1993).
6. Chadwick, B. P. & Willard, H. F. Chromatin of the Barr body: histone and
non-histone proteins associated with or excluded from the inactive
X chromosome. Hum. Mol. Genet. 12, 2167–2178 (2003).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12354
10 NATURE COMMUNICATIONS | 7:12354 |DOI: 10.1038/ncomms12354 | www.nature.com/naturecommunications
7. Chaumeil, J., Okamoto, I., Guggiari, M. & Heard, E. Integrated kinetics of
X chromosome inactivation in differentiating embryonic stem cells. Cytogenet.
Genome Res. 99, 75–84 (2002).
8. Hellman, A. & Chess, A. Gene body-speciﬁc methylation on the active X
chromosome. Science 315, 1141–1143 (2007).
9. Brown, C. J. & Willard, H. F. The human X-inactivation centre is not
required for maintenance of X-chromosome inactivation. Nature 368, 154–156
(1994).
10. Csankovszki, G., Panning, B., Bates, B., Pehrson, J. R. & Jaenisch, R.
Conditional deletion of Xist disrupts histone macroH2A localization but not
maintenance of X inactivation. Nat. Genet. 22, 323–324 (1999).
11. Kalantry, S. & Magnuson, T. The Polycomb group protein EED is dispensable
for the initiation of random X-chromosome inactivation. PLoS Genet. 2, e66
(2006).
12. Schoeftner, S. et al. Recruitment of PRC1 function at the initiation of X
inactivation independent of PRC2 and silencing. EMBO J 25, 3110–3122
(2006).
13. Csankovszki, G., Nagy, A. & Jaenisch, R. Synergism of Xist RNA, DNA
methylation, and histone hypoacetylation in maintaining X chromosome
inactivation. J. Cell Biol. 153, 773–784 (2001).
14. Zhang, L. F., Huynh, K. D. & Lee, J. T. Perinucleolar targeting of the inactive X
during S phase: evidence for a role in the maintenance of silencing. Cell 129,
693–706 (2007).
15. Ohhata, T. & Wutz, A. Reactivation of the inactive X chromosome in
development and reprogramming. Cell. Mol. Life Sci. 70, 2443–2461 (2013).
16. Donohoe, M. E., Silva, S. S., Pinter, S. F., Xu, N. & Lee, J. T. The pluripotency
factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and
counting. Nature 460, 128–132 (2009).
17. Gontan, C. et al. RNF12 initiates X-chromosome inactivation by targeting
REX1 for degradation. Nature 485, 386–390 (2012).
18. Navarro, P. et al. Molecular coupling of Xist regulation and pluripotency.
Science 321, 1693–1695 (2008).
19. Pasque, V. et al. X chromosome reactivation dynamics reveal stages of
reprogramming to pluripotency. Cell 159, 1681–1697 (2014).
20. Hanna, J. et al. Human embryonic stem cells with biological and epigenetic
characteristics similar to those of mouse ESCs. Proc. Natl Acad. Sci. USA 107,
9222–9227 (2010).
21. Lengner, C. J. et al. Derivation of pre-X inactivation human embryonic
stem cells under physiological oxygen concentrations. Cell 141, 872–883
(2010).
22. Mekhoubad, S. et al. Erosion of dosage compensation impacts human iPSC
disease modeling. Cell Stem Cell 10, 595–609 (2012).
23. Nazor, K. L. et al. Recurrent variations in DNA methylation in human
pluripotent stem cells and their differentiated derivatives. Cell Stem Cell 10,
620–634 (2012).
24. Pomp, O. et al. Unexpected X chromosome skewing during culture and
reprogramming of human somatic cells can be alleviated by exogenous
telomerase. Cell Stem Cell 9, 156–165 (2011).
25. Barakat, T. S. et al. Stable X chromosome reactivation in female human induced
pluripotent stem cells. Stem Cell Reports 4, 199–208 (2015).
26. Kim, K. Y. et al. X chromosome of female cells shows dynamic changes in
status during human somatic cell reprogramming. Stem Cell Reports 2, 896–909
(2014).
27. Vallot, C. et al. Erosion of X chromosome inactivation in human pluripotent
cells initiates with XACT coating and depends on a speciﬁc heterochromatin
landscape. Cell Stem Cell 16, 533–546 (2015).
28. Wutz, A. Epigenetic alterations in human pluripotent stem cells: a tale of two
cultures. Cell Stem Cell 11, 9–15 (2012).
29. Takagi, N., Yoshida, M. A., Sugawara, O. & Sasaki, M. Reversal of
X-inactivation in female mouse somatic cells hybridized with murine
teratocarcinoma stem cells in vitro. Cell 34, 1053–1062 (1983).
30. Yoshida, I., Nishita, Y., Mohandas, T. K. & Takagi, N. Reactivation of an
inactive human X chromosome introduced into mouse embryonal carcinoma
cells by microcell fusion with persistent expression of XIST. Exp. Cell Res. 230,
208–219 (1997).
31. Mohandas, T., Sparkes, R. S. & Shapiro, L. J. Reactivation of an inactive human
X chromosome: evidence for X inactivation by DNA methylation. Science 211,
393–396 (1981).
32. Hansen, R. S., Ellis, N. A. & Gartler, S. M. Demethylation of speciﬁc sites in the
50 region of the inactive X-linked human phosphoglycerate kinase gene
correlates with the appearance of nuclease sensitivity and gene expression.
Mol. Cell. Biol. 8, 4692–4699 (1988).
33. Hansen, R. S. & Gartler, S. M. 5-Azacytidine-induced reactivation of the human
X chromosome-linked PGK1 gene is associated with a large region of cytosine
demethylation in the 50 CpG island. Proc. Natl Acad. Sci. USA 87, 4174–4178
(1990).
34. Hansen, R. S., Canﬁeld, T. K., Stanek, A. M., Keitges, E. A. & Gartler, S. M.
Reactivation of XIST in normal ﬁbroblasts and a somatic cell hybrid: abnormal
localization of XIST RNA in hybrid cells. Proc. Natl Acad. Sci. USA 95,
5133–5138 (1998).
35. Thorogood, N. P. & Brown, C. J. Active chromatin marks are retained on
X chromosomes lacking gene or repeat silencing despite XIST/Xist expression
in somatic cell hybrids. PLoS ONE 5, e10787 (2010).
36. Schall, D. & Rechsteiner, M. Kinetics of human chromosome loss from
3T3-human hybrid cells. Somatic Cell Genet. 4, 661–676 (1978).
37. Pereira, C. F. et al. Heterokaryon-based reprogramming of human B
lymphocytes for pluripotency requires Oct4 but not Sox2. PLoS Genet. 4,
e1000170 (2008).
38. Piccolo, F. M. et al. Using heterokaryons to understand pluripotency and
reprogramming. Philos. Trans. R. Soc. Lond. B., Biol. Sci. 366, 2260–2265
(2011).
39. Harris, H., Watkins, J. F., Ford, C. E. & Schoeﬂ, G. I. Artiﬁcial heterokaryons of
animal cells from different species. J. Cell Sci. 1, 1–30 (1966).
40. Tsubouchi, T. et al. DNA synthesis is required for reprogramming mediated by
stem cell fusion. Cell 152, 873–883 (2013).
41. Brady, J. J. et al. Early role for IL-6 signalling during generation of induced
pluripotent stem cells revealed by heterokaryon RNA-Seq. Nat. Cell Biol. 15,
1244–1252 (2013).
42. Minkovsky, A. et al. The pluripotency factor-bound intron 1 of Xist is
dispensable for X chromosome inactivation and reactivation in vitro and
in vivo. Cell Rep. 3, 905–918 (2013).
43. Hall, L. L., Byron, M., Pageau, G. & Lawrence, J. B. AURKB-mediated effects on
chromatin regulate binding versus release of XIST RNA to the inactive
chromosome. J. Cell Biol. 186, 491–507 (2009).
44. Vallot, C. et al. XACT, a long noncoding transcript coating the active X
chromosome in human pluripotent cells. Nat. Genet. 45, 239–241 (2013).
45. Chu, C. et al. Systematic discovery of Xist RNA binding proteins. Cell 161,
404–416 (2015).
46. Moindrot, B. et al. A pooled shRNA screen identiﬁes Rbm15, Spen, and Wtap
as factors required for Xist RNA-mediated silencing. Cell Rep. 12, 562–572
(2015).
47. Monfort, A. et al. Identiﬁcation of Spen as a crucial factor for Xist function
through forward genetic screening in haploid embryonic stem cells. Cell Rep.
12, 554–561 (2015).
48. Chuva de Sousa Lopes, S. M. et al. X chromosome activity in mouse XX
primordial germ cells. PLoS Genet. 4, e30 (2008).
49. Sugimoto, M. & Abe, K. X chromosome reactivation initiates in nascent
primordial germ cells in mice. PLoS Genet. 3, e116 (2007).
50. Pereira, C. F. et al. ESCs require PRC2 to direct the successful reprogramming
of differentiated cells toward pluripotency. Cell Stem Cell 6, 547–556 (2010).
51. Okamoto, I. et al. Eutherian mammals use diverse strategies to initiate
X-chromosome inactivation during development. Nature 472, 370–374 (2011).
52. Wutz, A. & Jaenisch, R. A shift from reversible to irreversible X inactivation is
triggered during ES cell differentiation. Mol. Cell 5, 695–705 (2000).
53. Tchieu, J. et al. Female human iPSCs retain an inactive X chromosome. Cell
Stem Cell 7, 329–342 (2010).
54. Tomoda, K. et al. Derivation conditions impact X-inactivation status in female
human induced pluripotent stem cells. Cell Stem Cell 11, 91–99 (2012).
55. Takashima, Y. et al. Resetting transcription factor control circuitry toward
ground-state pluripotency in human. Cell 158, 1254–1269 (2014).
56. Robinton, D. A. & Daley, G. Q. The promise of induced pluripotent stem cells
in research and therapy. Nature 481, 295–305 (2012).
57. Niwa, H., Masui, S., Chambers, I., Smith, A. G. & Miyazaki, J. Phenotypic
complementation establishes requirements for speciﬁc POU domain and
generic transactivation function of Oct-3/4 in embryonic stem cells. Mol. Cell.
Biol. 22, 1526–1536 (2002).
58. Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25
years of image analysis. Nat. Methods 9, 671–675 (2012).
59. Iannuccelli, E. et al. NEMO: a tool for analyzing gene and chromosome
territory distributions from 3D-FISH experiments. Bioinformatics 26, 696–697
(2010).
60. Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of
insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
61. Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics
25, 2078–2079 (2009).
62. Calabrese, J. M. et al. Site-speciﬁc silencing of regulatory elements as a
mechanism of X inactivation. Cell 151, 951–963 (2012).
63. Hall, L. L. et al. Stable C0T-1 repeat RNA is abundant and is associated with
euchromatic interphase chromosomes. Cell 156, 907–919 (2014).
Acknowledgements
We thank J.B. Lawrence for providing G1A XIST plasmid, K.E. Brown and H. Bacgi for
communicating unpublished data, and P. Hajkova, T. Lavagnolli and A. Malinowski for
critical reading of the manuscript. These studies were supported by EMBO (I.C.), the
Human Frontiers in Science Programme (I.C.), the European Research Council
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12354 ARTICLE
NATURE COMMUNICATIONS | 7:12354 |DOI: 10.1038/ncomms12354 | www.nature.com/naturecommunications 11
(A.G.F. and H.B.) and Institutional support provided by the Medical Research Council
(D.D., G.D., M.M. and A.G.F.).
Author contributions
I.C. and A.G.F. conceived the study and wrote the manuscript. N.B. and M.M.
contributed to experimental design. I.C. performed experiments and data analysis with
the help of H.B. and technical support from T.N., R.C., E.H., C.V. and C.R. D.D.
developed a software for semi-automated image acquizition and analysis. I.C. and G.D.
performed bioinformatic analysis. All the authors revised and approved the manuscript.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Cantone, I. et al. Ordered chromatin changes and human
X chromosome reactivation by cell fusion-mediated pluripotent reprogramming.
Nat. Commun. 7:12354 doi: 10.1038/ncomms12354 (2016).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2016
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12354
12 NATURE COMMUNICATIONS | 7:12354 |DOI: 10.1038/ncomms12354 | www.nature.com/naturecommunications
